Mixed
Metabolic dysfunction (Metabolic Syndrome) significantly increases CHD risk regardless of body weight, with metabolically unhealthy normal weight individuals having more than double the risk of metabolically healthy normal weight individuals.
If you are normal weight, you are not immune to heart disease. If you have high blood pressure, high triglycerides, low HDL, high blood sugar, or a large waist, your risk is more than double that of a normal weight person with healthy metabolic markers. Address these metabolic issues through lifestyle changes or medication.
MetS was strongly positively associated with CHD risk, regardless of adiposity, with a HR of 2.15 (95% CI 1.79, 2.57: p<0.0001) for metabolically unhealthy normal weight participants with MetS
Why this rating
Large sample size, robust statistical adjustment, consistent results across sensitivity analyses.
Source
Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis
Camille Lassale et al. · European Heart Journal · 2017
DOI 10.1093/eurheartj/ehx448
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →